Detalhe da pesquisa
1.
The contemporary management of cancers of the sinonasal tract in adults.
CA Cancer J Clin
; 73(1): 72-112, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35916666
2.
Emerging tyrosine kinase inhibitors for head and neck cancer.
Expert Opin Emerg Drugs
; 27(3): 333-344, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36131561
3.
EGFR-targeted therapies in the post-genomic era.
Cancer Metastasis Rev
; 36(3): 463-473, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28866730
4.
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
Cancer
; 124(19): 3881-3889, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30291796
5.
HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Annu Rev Med
; 67: 91-101, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26332002
6.
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.
BMC Cancer
; 18(1): 1107, 2018 Nov 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30419840
7.
An update: emerging drugs to treat squamous cell carcinomas of the head and neck.
Expert Opin Emerg Drugs
; 23(4): 283-299, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30376740
8.
Cancer genomics: Spot the difference.
Nature
; 541(7636): 162-163, 2017 01 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28052059
9.
Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.
Int J Mol Sci
; 19(6)2018 May 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29848966
10.
TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
Genes Chromosomes Cancer
; 56(6): 460-471, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28177558
11.
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
Proc Natl Acad Sci U S A
; 111(3): 1114-9, 2014 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-24395800
12.
Characterization of HPV and host genome interactions in primary head and neck cancers.
Proc Natl Acad Sci U S A
; 111(43): 15544-9, 2014 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25313082
13.
Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.
Bioorg Med Chem Lett
; 26(15): 3581-5, 2016 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27381083
14.
Incidence of head and neck squamous cell carcinoma among subjects at high risk of lung cancer: results from the Pittsburgh Lung Screening Study.
Cancer
; 121(9): 1431-5, 2015 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25559556
15.
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
BMC Cancer
; 15: 861, 2015 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26545583
16.
Emerging drugs for head and neck cancer.
Expert Opin Emerg Drugs
; 20(2): 313-29, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25826749
17.
Receptor-type protein tyrosine phosphatases in cancer.
Chin J Cancer
; 34(2): 61-9, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25322863
18.
Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effects.
Mol Med
; 20: 46-56, 2014 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-24395569
19.
2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.
Bioorg Med Chem Lett
; 24(21): 5081-5, 2014 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25288188
20.
Career trajectories of MD-PhD physician scientists: The loss of women investigators.
Cancer Cell
; 42(5): 723-726, 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38701793